RETA

Reata Pharmaceuticals, Inc. Class A Common Stock

Delisted

RETA was delisted on the 25th of September, 2023.

194 hedge funds and large institutions have $3.75B invested in Reata Pharmaceuticals, Inc. Class A Common Stock in 2021 Q2 according to their latest regulatory filings, with 34 funds opening new positions, 69 increasing their positions, 66 reducing their positions, and 40 closing their positions.

New
Increased
Maintained
Reduced
Closed

more funds holding in top 10

Funds holding in top 10:

more capital invested

Capital invested by funds: $ → $

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

less funds holding

Funds holding:

15% less first-time investments, than exits

New positions opened: 34 | Existing positions closed: 40

44% less call options, than puts

Call options by funds: $30.4M | Put options by funds: $54.7M

Holders
194
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
7
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$30.4M
Puts
$54.7M
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
51
$5.55M
52
$5.41M
53
$5.36M
54
$5.11M
55
$5M
56
$4.93M
57
$4.91M
58
$4.86M
59
$4.84M
60
$4.52M
61
$4.3M
62
$4.27M
63
$4.26M
64
$4.24M
65
$3.91M
66
$3.82M
67
$3.76M
68
$3.64M
69
$3.51M
70
$3.35M
71
$3.35M
72
$3.09M
73
$2.97M
74
$2.83M
75
$2.83M